Table 2.
Subject characteristics relative to glioma grade, IDH mutation, and MGMT methylation
| a. Subject characteristics relative to glioma grade | |||
| Low Grade (n = 28) | High Grade (n= 79) | p-value | |
| Sex (male) | 14 (50%) | 46 (58.22%) | 0.451 |
| Age (years) | 33.32 (12.44) | 50.35 (13.90) | < 0.001* |
| Ki-67b | 7.12 (13.61) | 24.86 (19.09) | < 0.001* |
| b. Subject characteristics relative to IDH mutation statusa | |||
| Mutant (n = 24) | Wildtype (n= 81) | p-value | |
| Sex (male) | 17 (70.83%) | 42 (51.85%) | 0.254 |
| Age (years) | 37.42 (10.54) | 48.39 (15.99) | 0.002* |
| Ki-67b | 16.61 (18.01) | 21.75 (19.86) | 0.261 |
| c. Subject characteristics relative to MGMT methylation status | |||
| Methylated (n= 30) | Unmethylated (n= 77) | p-value | |
| Sex (male) | 16 (53.33%) | 44 (57.14%) | 0.721 |
| Age (years) | 48.30 (11.4) | 44.96 (16.71) | 0.317 |
| Ki-67b | 15.14 (18.05) | 22.32 (19.67) | 0.087 |
Chi-Squared Test and Independent Samples T-Test were utilized as appropriate. Data are presented as number (percentage) or mean (standard errors)
IDH Isocitrate dehydrogenase, MGMT Methylguanine DNA‐methyltransferase
*denotes statistically significant p value of less than 0.05
adata missing (n = 2)
bdata missing (n = 3)